• Revenue: Q4 rental revenue decreased to $32.9 million, reflecting property dispositions and rent reserves.

• Net Income: Q4 net loss attributable to common stockholders was $0.8 million, a decline from the prior year's net income.

• FFO and AFFO: Q4 FFO stood at $13.3 million ($0.19 per share and unit), and AFFO was $15.9 million ($0.23 per share and unit).

• Portfolio Performance: Portfolio occupancy at 96.5% with an annualized base rent of $110.2 million.

• Leverage: Year-end leverage reduced to 43.6%, with total debt outstanding of $611.2 million.

• Dividends: Declared Q4 cash dividend of $0.21 per share for common stockholders and unitholders.

• Acquisition Pipeline: Approximately $95 million to $110 million of properties fit for investment criteria.

• Warning! GuruFocus has detected 8 Warning Signs with GMRE.

On February 27, 2024, Global Medical REIT Inc (NYSE:GMRE) released its 8-K filing, outlining its financial results for the fourth quarter and full year ended December 31, 2023. The Maryland-based corporation, which specializes in acquiring healthcare facilities and leasing them to healthcare systems and physician groups, reported a decrease in rental revenue for the fourth quarter to $32.9 million. This decline was primarily due to property dispositions completed during the first nine months of 2023 and the recognition of reserves for rent related to a medical office building tenant.

Despite the challenges posed by high interest rates affecting transaction activity in the market, GMRE managed to generate $80.5 million in gross proceeds from dispositions, which contributed to reducing the company's leverage to 43.6% at year-end. Jeffrey M. Busch, Chairman, CEO, and President of GMRE, expressed appreciation for the team's efforts and optimism for a strong acquisition pipeline in 2024.

Financial Performance and Portfolio Health

GMRE's total expenses for the fourth quarter were $31.5 million, a decrease from the $34.5 million reported in the same period of the previous year. This reduction in expenses was attributed to the impact of property dispositions and a decrease in interest expense, which fell to $7.0 million from $8.1 million year-over-year.

The company's net loss attributable to common stockholders for the fourth quarter was $0.8 million, or $0.01 per diluted share, compared to a net income of $0.4 million, or $0.01 per diluted share, in the prior year period. Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO) for the fourth quarter were reported at $13.3 million and $15.9 million, respectively, reflecting a slight decrease from the comparable prior year period.